The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes Molecular Medicine Springer Nature Link Doping control analysis of small peptides: A decade of progress ScienceDirect ARA 290 in Autoimmune Diseases Australia Research Our peptide lineup is designed to help you optimize every aspect of your healthfrom metabolism and recovery to brain performance and longevity. Now introducing: AOD 9604 ARA 290 BPC 157 DSIP Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle to Bone Reattachment in Rats